0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessCyclin-dependent kinase 4/6 inhibitors have transformed hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer therapeutics. Ribociclib has been associated with survival gain, yet its potentia
Oraianthi Fiste, Martina Samiotaki, Efstathios Manios, Chrysanthi Trika, Christine‐Ivy Liacos, Constantine Dimitrakakis, Meletios A Dimopoulos, Maria Gavriatopoulou, Flora Zagouri (2025). Serum Proteomics of Ribociclib-Mediated Cardiovascular Toxicity: An Exploratory Case-Control Study. , DOI: https://doi.org/10.22541/au.174055876.60803084/v1.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Preprint
Year
2025
Authors
9
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.22541/au.174055876.60803084/v1
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
